AJP - Regulatory, Integrative and Comparative Physiology, Vol 268, Issue 5 1137-R1142, Copyright © 1995 by American Physiological Society

ARTICLES

L-arginine analogues inhibit aldosterone secretion in rats

J. C. Simmons and R. H. Freeman
Department of Physiology, University of Missouri School of Medicine, Columbia 65212, USA.

L-Arginine analogues, e.g., NG-nitro-L-arginine methyl ester (L-NAME), increase arterial pressure and suppress renin release in the rat. On the basis of these observations, it was hypothesized that L-arginine analogues also would attenuate aldosterone secretion. This hypothesis was tested in anesthetized rats treated with L-NAME or NG-nitro-L-arginine (L-NNA, 185 mumol/kg ip). The aldosterone secretion rate, plasma renin activity, and adrenal blood flow were attenuated in rats treated with L-NAME and L-NNA compared with control animals. Similar experiments were performed in anephric rats to examine the effects of L-NAME on aldosterone secretion independent of the circulating reninangiotensin system. The administration of L-NAME reduced adrenal blood flow but failed to reduce aldosterone secretion in these anephric rats. Bilateral nephrectomy reduced plasma renin activity essentially to undetectable levels in these animals. In a third series of experiments, two groups of anephric rats were infused with angiotensin II (3 micrograms/kg body wt iv) to provide a stimulus for aldosterone secretion. Aldosterone secretion and adrenal blood flow were markedly reduced in angiotensin II-infused rats pretreated with L-NAME compared with the control anephric animals infused with angiotensin II. Overall these results suggest that L-arginine analogues attenuate aldosterone secretion by inhibiting the adrenal steroidogenic effects of endogenous or exogenous angiotensin II and/or by reducing plasma levels of renin/angiotensin.

This article has been cited by other articles:

				K. Nithipatikom, B. B. Holmes, M. J. McCoy, C. J. Hillard, and W. B. Campbell Chronic administration of nitric oxide reduces angiotensin II receptor type 1 expression and aldosterone synthesis in zona glomerulosa cells Am J Physiol Endocrinol Metab, November 1, 2004; 287(5): E820 - E827. [Abstract] [Full Text] [PDF]

				A. Russell, A. Banes, H. Berlin, G. D. Fink, and S. W. Watts 5-Hydroxytryptamine2B Receptor Function Is Enhanced in the Nomega -Nitro-L-arginine Hypertensive Rat J. Pharmacol. Exp. Ther., October 1, 2002; 303(1): 179 - 187. [Abstract] [Full Text] [PDF]

				R. Salemi, J. G. McDougall, K. J. Hardy, and E. M. Wintour Local inhibition of nitric oxide temporarily stimulates aldosterone secretion in conscious sheep in vivo Am J Physiol Endocrinol Metab, April 1, 2001; 280(4): E584 - E590. [Abstract] [Full Text] [PDF]

				A. Kurtz and C. Wagner Role of nitric oxide in the control of renin secretion Am J Physiol Renal Physiol, December 1, 1998; 275(6): F849 - F862. [Abstract] [Full Text] [PDF]

				M. Usui, T. Ichiki, M. Katoh, K. Egashira, and A. Takeshita Regulation of Angiotensin II Receptor Expression by Nitric Oxide in Rat Adrenal Gland Hypertension, September 1, 1998; 32(3): 527 - 533. [Abstract] [Full Text] [PDF]

				P. R. Knoblich, R. H. Freeman, and D. Villarreal Pressure-Dependent Renin Release During Chronic Blockade of Nitric Oxide Synthase Hypertension, November 1, 1996; 28(5): 738 - 742. [Abstract] [Full Text]